Anthera Pharmaceuticals Reports 2015 First Quarter and Operational Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Citi Upgrades Anthera Pharma (ANTH) to Neutral
May 12, 2015 7:25 AM EDTCiti upgraded Anthera Pharma (NASDAQ: ANTH) from Sell to Neutral.
For an analyst ratings summary and ratings history on Anthera Pharma click here. For more ratings news on Anthera Pharma click here.
Shares of Anthera Pharma closed at $4.48 yesterday.
... MoreAnthera Pharma (ANTH) Tops Q1 EPS by 3c
May 11, 2015 5:31 PM EDTAnthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.
... More